Rational evolution for altering the ligand preference of estrogen receptor alpha
Protein Science · 2024-04 · 33 (4)
DOI: 10.1002/pro.4940 ↗At a glance
Journal article in Protein Science, published online on 2024-03-21. Written by Roy Eerlings and 19 co-authors. Institution: Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium. Major MEDLINE topics: Estrogen Receptor alpha, Estradiol. Cited 3 times so far (Crossref); 68 references. The full text is freely available in PubMed Central. Funded by: KU Leuven.
Abstract (original language)
Estrogen receptor α is commonly used in synthetic biology to control the activity of genome editing tools. The activating ligands, estrogens, however, interfere with various cellular processes, thereby limiting the applicability of this receptor. Altering its ligand preference to chemicals of choice solves this hurdle but requires adaptation of unspecified ligand‐interacting residues. Here, we provide a solution by combining rational protein design with multi‐site‐directed mutagenesis and directed evolution of stably integrated variants in Saccharomyces cerevisiae. This method yielded an estrogen receptor variant, named TERRA, that lost its estrogen responsiveness and became activated by tamoxifen, an anti‐estrogenic drug used for breast cancer treatment. This tamoxifen preference of TERRA was maintained in mammalian cells and mice, even when fused to Cre recombinase, expanding the mammalian synthetic biology toolbox. Not only is our platform transferable to engineer ligand preference of any steroid receptor, it can also profile drug‐resistance landscapes for steroid receptor‐targeted therapies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
- Laboratory of Systems Biology, VIB-KU Leuven Center for Microbiology, Leuven, Belgium.
- Laboratory for Genetics and Genomics, Center of Microbial and Plant Genetics, Department M2S, KU Leuven, Heverlee, Belgium.
- Laboratory of Biomolecular Modelling and Design, Department of Chemistry, KU Leuven, Heverlee, Belgium.
- Department of Urology, University Hospitals Leuven, Leuven, Belgium.
- Laboratory of Viral Cell Biology and Therapeutics, Department of Cellular and Molecular Medicine, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
ORCID profiles: Roy Eerlings, Karin Voordeckers, Arnout Voet, Christine Helsen
Funding
- KU Leuven
Cite
APA
Eerlings, R., Gupta, P., Lee, X. Y., Nguyen, T., El Kharraz, S., Handle, F., Smeets, E., Moris, L., Devlies, W., Vandewinkel, B., Thiry, I., Ta, D. T., Gorkovskiy, A., Voordeckers, K., Henckaerts, E., Pinheiro, V. B., Claessens, F., Verstrepen, K. J., Voet, A., & Helsen, C. (2024). Rational evolution for altering the ligand preference of estrogen receptor alpha. Protein Science, 33(4). https://doi.org/10.1002/pro.4940
Vancouver
Eerlings R, Gupta P, Lee XY, Nguyen T, El Kharraz S, Handle F, et al. Rational evolution for altering the ligand preference of estrogen receptor alpha. Protein Science. 2024;33(4). doi:10.1002/pro.4940
BibTeX
@article{Eerlings2024,
author = {Eerlings, Roy and Gupta, Purvi and Lee, Xiao Yin and Nguyen, Tien and El Kharraz, Sarah and Handle, Florian and Smeets, Elien and Moris, Lisa and Devlies, Wout and Vandewinkel, Bram and Thiry, Irina and Ta, Duy Tien and Gorkovskiy, Anton and Voordeckers, Karin and Henckaerts, Els and Pinheiro, Vitor B and Claessens, Frank and Verstrepen, Kevin J and Voet, Arnout and Helsen, Christine},
title = {Rational evolution for altering the ligand preference of estrogen receptor alpha},
journal = {Protein Science},
year = {2024},
volume = {33},
number = {4},
doi = {10.1002/pro.4940}
}
EUVIMED